当前位置:循环首页>正文

[IHF2010]经导管主动脉瓣置入术——G.P.Ussia教授专访

作者:  G.P.Ussia教授   日期:2010/8/29 14:39:00

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

<International Circulation>: Improvements in heathcare actually leads to the increase in the incidence of some conditions, such as aortic valve calcification. Aortic valve calcification in elderly patients can cause aortic stenosis and because age has increased risk for all kinds of complications and multiple organ dysfunctions, the risk of surgery is very high. Recently, percutaneous aortic valve implantation has presented itself as an appropriate therapy for these special patients. Can you outline the indications and contraindications for the procedure?

    <International Circulation>: We know the new technology has encouraging prospects in the eyes of clinicians and of course it is paramount to pay attention to safety. What is your view on the safety of percutaneous aortic valve implantation?

    Dr Ussia: Where the procedure is successful the outcomes are impressive. From European national registries data we see the procedural success is around 97% to 98%, and the 30 day all cause mortality is around 8% which is lower than the expected mortality rate for cardiac surgery as predicted by surgical risk scores .
So the safety and efficacy of the transcatheter aortic valve implantation are good and very encouraging for the future.
 

上一页  [1]  [2]  [3]  

版面编辑:沈会会  责任编辑:张衡



G.P.Ussia教授 冠心病 经导管主动脉瓣置入术

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530